Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 294

1.

Primary visual cortex excitability is not atypical in acquired synaesthesia.

Lungu L, Stewart R, Luke DP, Terhune DB.

Brain Stimul. 2019 Nov 4. pii: S1935-861X(19)30430-9. doi: 10.1016/j.brs.2019.10.021. [Epub ahead of print] No abstract available.

2.

Social Network Mapping and Functional Recovery Within 6 Months of Ischemic Stroke.

Dhand A, Lang CE, Luke DA, Kim A, Li K, McCafferty L, Mu Y, Rosner B, Feske SK, Lee JM.

Neurorehabil Neural Repair. 2019 Nov;33(11):922-932. doi: 10.1177/1545968319872994. Epub 2019 Sep 15.

PMID:
31524080
3.

Modelling the impact of menthol sales restrictions and retailer density reduction policies: insights from tobacco town Minnesota.

Combs TB, McKay VR, Ornstein J, Mahoney M, Cork K, Brosi D, Kasman M, Heuberger B, Hammond RA, Luke D.

Tob Control. 2019 Aug 28. pii: tobaccocontrol-2019-054986. doi: 10.1136/tobaccocontrol-2019-054986. [Epub ahead of print]

4.

Acquired synaesthesia following 2C-B use.

Yanakieva S, Luke DP, Jansari A, Terhune DB.

Psychopharmacology (Berl). 2019 Jul;236(7):2287-2289. doi: 10.1007/s00213-019-05242-y. Epub 2019 Apr 26. No abstract available.

PMID:
31025060
5.

Social networks and risk of delayed hospital arrival after acute stroke.

Dhand A, Luke D, Lang C, Tsiaklides M, Feske S, Lee JM.

Nat Commun. 2019 Mar 14;10(1):1206. doi: 10.1038/s41467-019-09073-5.

6.

Concordance of Advertised Cigarette Prices with Purchase Receipts in the United States.

Schleicher NC, Johnson TO, D'Angelo H, Luke DA, Ribisl KM, Henriksen L.

Tob Regul Sci. 2018 May;4(3):3-9. doi: 10.18001/TRS.4.3.1.

7.

Three Changes Public Health Scientists Can Make to Help Build a Culture of Reproducible Research.

Harris JK, Combs TB, Johnson KJ, Carothers BJ, Luke DA, Wang X.

Public Health Rep. 2019 Mar/Apr;134(2):109-111. doi: 10.1177/0033354918821076. Epub 2019 Jan 18. No abstract available.

PMID:
30657732
8.

Genetic associations of inflammatory bowel disease in a South Asian population.

Niriella MA, Liyanage IK, Kodisinghe SK, Silva AP, Rajapakshe N, Nanayakkara SD, Luke D, Silva T, Nawarathne M, Peiris RK, Kalubovila UP, Kumarasena SR, Dissanayake VHW, Jayasekara RW, de Silva HJ.

World J Clin Cases. 2018 Dec 6;6(15):908-915. doi: 10.12998/wjcc.v6.i15.908.

9.

The effects of microdose LSD on time perception: a randomised, double-blind, placebo-controlled trial.

Yanakieva S, Polychroni N, Family N, Williams LTJ, Luke DP, Terhune DB.

Psychopharmacology (Berl). 2019 Apr;236(4):1159-1170. doi: 10.1007/s00213-018-5119-x. Epub 2018 Nov 26.

10.

Developing an evidence-based program sustainability training curriculum: a group randomized, multi-phase approach.

Vitale R, Blaine T, Zofkie E, Moreland-Russell S, Combs T, Brownson RC, Luke DA.

Implement Sci. 2018 Sep 26;13(1):126. doi: 10.1186/s13012-018-0819-5.

11.

Use of reproducible research practices in public health: A survey of public health analysts.

Harris JK, Johnson KJ, Carothers BJ, Combs TB, Luke DA, Wang X.

PLoS One. 2018 Sep 12;13(9):e0202447. doi: 10.1371/journal.pone.0202447. eCollection 2018.

12.

Preoperative cystoscopy could determine the severity of placenta accreta spectrum disorders: An observational study.

Al-Khan A, Guirguis G, Zamudio S, Alvarez M, Martimucci K, Luke D, Alvarez-Perez J.

J Obstet Gynaecol Res. 2019 Jan;45(1):126-132. doi: 10.1111/jog.13794. Epub 2018 Aug 23.

13.

Phase 1 Study of the Pharmacology of BTI320 Before High-Glycemic Meals.

Luke DR, Lee KKY, Rausch CW, Cheng C.

Clin Pharmacol Drug Dev. 2019 Apr;8(3):395-403. doi: 10.1002/cpdd.583. Epub 2018 Jun 5.

14.

Rural Health Networks: How Network Analysis Can Inform Patient Care and Organizational Collaboration in a Rural Breast Cancer Screening Network.

Prusaczyk B, Maki J, Luke DA, Lobb R.

J Rural Health. 2019 Mar;35(2):222-228. doi: 10.1111/jrh.12302. Epub 2018 Apr 15.

PMID:
29656463
15.

ASHP Guidelines for the Management of Investigational Drug Products.

Kay SC, Luke DG, Tamer HR.

Am J Health Syst Pharm. 2018 Apr 15;75(8):561-573. doi: 10.2146/ajhp170812. No abstract available.

PMID:
29626006
16.

Clinical Pharmacokinetics of Sulfobutylether-β-Cyclodextrin in Patients With Varying Degrees of Renal Impairment.

Hoover RK, Alcorn H Jr, Lawrence L, Paulson SK, Quintas M, Luke DR, Cammarata SK.

J Clin Pharmacol. 2018 Jun;58(6):814-822. doi: 10.1002/jcph.1077. Epub 2018 Mar 26.

17.

Toward optimal implementation of cancer prevention and control programs in public health: a study protocol on mis-implementation.

Padek M, Allen P, Erwin PC, Franco M, Hammond RA, Heuberger B, Kasman M, Luke DA, Mazzucca S, Moreland-Russell S, Brownson RC.

Implement Sci. 2018 Mar 23;13(1):49. doi: 10.1186/s13012-018-0742-9.

18.

Human trophoblast epithelial-mesenchymal transition in abnormally invasive placenta.

DaSilva-Arnold SC, Zamudio S, Al-Khan A, Alvarez-Perez J, Mannion C, Koenig C, Luke D, Perez AM, Petroff M, Alvarez M, Illsley NP.

Biol Reprod. 2018 Aug 1;99(2):409-421. doi: 10.1093/biolre/ioy042.

PMID:
29438480
19.

Sex Venue-Based Network Analysis to Identify HIV Prevention Dissemination Targets for Men Who Have Sex with Men.

Patel RR, Luke DA, Proctor EK, Powderly WG, Chan PA, Mayer KH, Harrison LC, Dhand A.

LGBT Health. 2018 Jan;5(1):78-85. doi: 10.1089/lgbt.2017.0018.

20.

Patient outcome of emergency laparotomy improved with increasing "number of surgeons on-call" in a university hospital: Audit loop.

Hussain A, Mahmood F, Teng C, Jafferbhoy S, Luke D, Tsiamis A.

Ann Med Surg (Lond). 2017 Sep 28;23:21-24. doi: 10.1016/j.amsu.2017.09.013. eCollection 2017 Nov.

21.

The Translational Science Benefits Model: A New Framework for Assessing the Health and Societal Benefits of Clinical and Translational Sciences.

Luke DA, Sarli CC, Suiter AM, Carothers BJ, Combs TB, Allen JL, Beers CE, Evanoff BA.

Clin Transl Sci. 2018 Jan;11(1):77-84. doi: 10.1111/cts.12495. Epub 2017 Sep 8.

22.

Building capacity for dissemination and implementation research: one university's experience.

Brownson RC, Proctor EK, Luke DA, Baumann AA, Staub M, Brown MT, Johnson M.

Implement Sci. 2017 Aug 16;12(1):104. doi: 10.1186/s13012-017-0634-4.

23.

Tobacco Town: Computational Modeling of Policy Options to Reduce Tobacco Retailer Density.

Luke DA, Hammond RA, Combs T, Sorg A, Kasman M, Mack-Crane A, Ribisl KM, Henriksen L.

Am J Public Health. 2017 May;107(5):740-746. doi: 10.2105/AJPH.2017.303685. Erratum in: Am J Public Health. 2017 Oct;107(10):e1.

24.

Disparities in tobacco marketing and product availability at the point of sale: Results of a national study.

Ribisl KM, D'Angelo H, Feld AL, Schleicher NC, Golden SD, Luke DA, Henriksen L.

Prev Med. 2017 Dec;105:381-388. doi: 10.1016/j.ypmed.2017.04.010. Epub 2017 Apr 6.

25.

Inequalities in tobacco outlet density by race, ethnicity and socioeconomic status, 2012, USA: results from the ASPiRE Study.

Lee JG, Sun DL, Schleicher NM, Ribisl KM, Luke DA, Henriksen L.

J Epidemiol Community Health. 2017 May;71(5):487-492. doi: 10.1136/jech-2016-208475. Epub 2017 Mar 1.

26.

Taking Stock of Tobacco Control Program and Policy Science and Impact in the United States.

Farrelly MC, Chaloupka FJ, Berg CJ, Emery SL, Henriksen L, Ling P, Leischow SJ, Luke DA, Kegler MC, Zhu SH, Ginexi EM.

J Addict Behav Ther. 2017;1(2). pii: 8. Epub 2017 Sep 15.

27.

The Case for a Concerted Push to Reduce Place-Based Disparities in Smoking-Related Cancers.

Ribisl KM, Luke DA, Henriksen L.

JAMA Intern Med. 2016 Dec 1;176(12):1799-1800. doi: 10.1001/jamainternmed.2016.6865. No abstract available.

28.

Forging a link between mentoring and collaboration: a new training model for implementation science.

Luke DA, Baumann AA, Carothers BJ, Landsverk J, Proctor EK.

Implement Sci. 2016 Oct 13;11(1):137.

29.

Comparing projected impacts of cigarette floor price and excise tax policies on socioeconomic disparities in smoking.

Golden SD, Farrelly MC, Luke DA, Ribisl KM.

Tob Control. 2016 Oct;25(Suppl 1):i60-i66. doi: 10.1136/tobaccocontrol-2016-053230.

30.

Tobacco retail policy landscape: a longitudinal survey of US states.

Luke DA, Sorg AA, Combs T, Robichaux CB, Moreland-Russell S, Ribisl KM, Henriksen L.

Tob Control. 2016 Oct;25(Suppl 1):i44-i51. doi: 10.1136/tobaccocontrol-2016-053075.

31.

Success in the city: the road to implementation of Tobacco 21 and Sensible Tobacco Enforcement in New York City.

Moreland-Russell S, Combs T, Schroth K, Luke D.

Tob Control. 2016 Oct;25(Suppl 1):i6-i9. doi: 10.1136/tobaccocontrol-2016-053089.

32.

Accuracy of Wearable Cameras to Track Social Interactions in Stroke Survivors.

Dhand A, Dalton AE, Luke DA, Gage BF, Lee JM.

J Stroke Cerebrovasc Dis. 2016 Dec;25(12):2907-2910. doi: 10.1016/j.jstrokecerebrovasdis.2016.08.004. Epub 2016 Sep 9.

33.

Social networks and neurological illness.

Dhand A, Luke DA, Lang CE, Lee JM.

Nat Rev Neurol. 2016 Oct;12(10):605-12. doi: 10.1038/nrneurol.2016.119. Epub 2016 Sep 12. Review.

34.

Reducing Disparities in Tobacco Retailer Density by Banning Tobacco Product Sales Near Schools.

Ribisl KM, Luke DA, Bohannon DL, Sorg AA, Moreland-Russell S.

Nicotine Tob Res. 2017 Feb;19(2):239-244. doi: 10.1093/ntr/ntw185. Epub 2016 Aug 26.

35.

Clinical Pharmacology of Delafloxacin in Patients With Hepatic Impairment.

Hoover R, Marbury TC, Preston RA, Quintas M, Lawrence LE, Paulson SK, Luke DR, Cammarata SK.

J Clin Pharmacol. 2017 Mar;57(3):328-335. doi: 10.1002/jcph.817. Epub 2016 Oct 14.

36.

A placebo-controlled investigation of synaesthesia-like experiences under LSD.

Terhune DB, Luke DP, Kaelen M, Bolstridge M, Feilding A, Nutt D, Carhart-Harris R, Ward J.

Neuropsychologia. 2016 Jul 29;88:28-34. doi: 10.1016/j.neuropsychologia.2016.04.005. Epub 2016 Apr 5.

37.

Academic Cross-Pollination: The Role of Disciplinary Affiliation in Research Collaboration.

Dhand A, Luke DA, Carothers BJ, Evanoff BA.

PLoS One. 2016 Jan 13;11(1):e0145916. doi: 10.1371/journal.pone.0145916. eCollection 2016.

38.

Reduced Social Network Drinking is Associated with Improved Response Inhibition in Women During Early Recovery from Alcohol Use Disorders: A Pilot Study.

McCutcheon VV, Luke DA, Lessov-Schlaggar CN.

Alcohol Clin Exp Res. 2016 Jan;40(1):170-7. doi: 10.1111/acer.12925. Epub 2015 Dec 21.

39.

Telavancin hospital-acquired pneumonia trials: impact of Gram-negative infections and inadequate Gram-negative coverage on clinical efficacy and all-cause mortality.

Lacy MK, Stryjewski ME, Wang W, Hardin TC, Nogid B, Luke DR, Shorr AF, Corey GR, Barriere SL.

Clin Infect Dis. 2015 Sep 15;61 Suppl 2:S87-93. doi: 10.1093/cid/civ536.

PMID:
26316562
40.

Ebony and Ivory? Interracial dating intentions and behaviors of disadvantaged African American women in Kentucky.

Luke DJ, Oser CB.

Soc Sci Res. 2015 Sep;53:338-50. doi: 10.1016/j.ssresearch.2015.06.016. Epub 2015 Jun 26.

41.

Sustainability of evidence-based healthcare: research agenda, methodological advances, and infrastructure support.

Proctor E, Luke D, Calhoun A, McMillen C, Brownson R, McCrary S, Padek M.

Implement Sci. 2015 Jun 11;10:88. doi: 10.1186/s13012-015-0274-5.

42.

Human adipose tissue as a reservoir for memory CD4+ T cells and HIV.

Couturier J, Suliburk JW, Brown JM, Luke DJ, Agarwal N, Yu X, Nguyen C, Iyer D, Kozinetz CA, Overbeek PA, Metzker ML, Balasubramanyam A, Lewis DE.

AIDS. 2015 Mar 27;29(6):667-74. doi: 10.1097/QAD.0000000000000599.

43.

Appraising the evidence for public health policy components using the quality and impact of component evidence assessment.

Barbero C, Gilchrist S, Schooley MW, Chriqui JF, Luke DA, Eyler AA.

Glob Heart. 2015 Mar;10(1):3-11. doi: 10.1016/j.gheart.2014.12.013. Review.

PMID:
25754561
44.

Calibration of the small bowel in stricture-forming small-bowel Crohn's disease.

Luke D, Bowley D, Mortensen N.

Ann R Coll Surg Engl. 2015 Jan;97(1):81-2. doi: 10.1308/rcsann.2015.97.1.81a. No abstract available.

45.

Breaking down silos: mapping growth of cross-disciplinary collaboration in a translational science initiative.

Luke DA, Carothers BJ, Dhand A, Bell RA, Moreland-Russell S, Sarli CC, Evanoff BA.

Clin Transl Sci. 2015 Apr;8(2):143-9. doi: 10.1111/cts.12248. Epub 2014 Dec 4.

46.

Reconstruction of wave front and object for inline holography from a set of detection planes.

Hagemann J, Robisch AL, Luke DR, Homann C, Hohage T, Cloetens P, Suhonen H, Salditt T.

Opt Express. 2014 May 19;22(10):11552-69. doi: 10.1364/OE.22.011552.

PMID:
24921276
47.

The Program Sustainability Assessment Tool: a new instrument for public health programs.

Luke DA, Calhoun A, Robichaux CB, Elliott MB, Moreland-Russell S.

Prev Chronic Dis. 2014 Jan 23;11:130184. doi: 10.5888/pcd11.130184.

48.

Using the Program Sustainability Assessment Tool to assess and plan for sustainability.

Calhoun A, Mainor A, Moreland-Russell S, Maier RC, Brossart L, Luke DA.

Prev Chronic Dis. 2014 Jan 23;11:130185. doi: 10.5888/pcd11.130185.

49.

Tocotrienol supplementation in postmenopausal osteoporosis: evidence from a laboratory study.

Muhammad N, Luke DA, Shuid AN, Mohamed N, Soelaiman IN.

Clinics (Sao Paulo). 2013 Oct;68(10):1338-43. doi: 10.6061/clinics/2013(10)08.

50.

The induction of synaesthesia with chemical agents: a systematic review.

Luke DP, Terhune DB.

Front Psychol. 2013 Oct 17;4:753. doi: 10.3389/fpsyg.2013.00753. Review.

Supplemental Content

Support Center